Market Tracker

10/24 4:32pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
24.11 +0.13 / +0.54%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
24.11 +0.0036 / +0.01%
 
Volume: 3.3K
No recent news for Repligen Corp.

Today’s Trading

Previous close23.98
Today’s open24.03
Day’s range23.79 - 24.43
Volume272,203
Average volume (3 months)391,585
Market cap$782.9M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-47.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio48.2
Price/Sales6.34
Price/Book7.37

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.15-0.69%
ASPXAuspex Pharmaceutica...+0.42+1.56%
ENTAEnanta Pharmaceutica...+0.20+0.44%
TTPHTetraphase Pharmaceu...+0.09+0.38%
Data as of 4:02pm ET, 10/24/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.05
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts